Gyftopoulos Argyrios, Ziogas Ioannis A, Barbas Andrew S, Moris Dimitrios
Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Department of Surgery, Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, United States.
Front Oncol. 2022 May 25;12:843769. doi: 10.3389/fonc.2022.843769. eCollection 2022.
Irreversible electroporation (IRE) is a local ablative technique used in conjunction with chemotherapy to treat locally advanced pancreatic cancer (LAPC). The combination of IRE and chemotherapy has showed increased overall survival when compared to chemotherapy alone, pointing towards a possible facilitating effect of IRE on chemotherapeutic drug action and delivery. This review aims to present current chemotherapeutic regimens for LAPC and their co-implementation with IRE, with an emphasis on possible molecular augmentative mechanisms of drug delivery and action. Moreover, the potentiating mechanism of IRE on immunotherapy, M1 oncolytic virus and dendritic cell (DC)-based treatments is briefly explored. Investigating the synergistic effect of IRE on currently established treatment regimens as well as newer ones, may present exciting new possibilities for future studies seeking to improve current LAPC treatment algorithms.
不可逆电穿孔(IRE)是一种局部消融技术,与化疗联合用于治疗局部晚期胰腺癌(LAPC)。与单纯化疗相比,IRE与化疗联合应用已显示出总生存期延长,这表明IRE对化疗药物的作用和递送可能具有促进作用。本综述旨在介绍目前用于LAPC的化疗方案及其与IRE的联合应用,重点关注药物递送和作用可能的分子增强机制。此外,还简要探讨了IRE对免疫治疗、M1溶瘤病毒和基于树突状细胞(DC)治疗的增强机制。研究IRE对目前既定治疗方案以及新方案的协同作用,可能为未来寻求改进当前LAPC治疗算法的研究带来令人兴奋的新可能性。